Kenvue Inc. logo

Kenvue Inc.

KVUE | NYSE
Chart Builder DCF Calculator
$19.31
-$0.25 (-1.28%)
At close: Oct 30, 2026, 4:00 PM ET
$19.42
+$0.11 (+0.57%)
After-hours: Oct 30, 2026, 7:45 PM ET

Company Profile

Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.

Key Executives

Name Position
Kirk L. Perry Chief Executive Officer & Director
Anil Agarwal Head of Total Rewards
Carlton Lawson Group President of Europe, Middle East & Africa
Caroline Tillett Chief Scientific Officer
Heather R. Howlett Interim CFO & Chief Accounting Officer
Jonathan Halvorson Chief Digital & Marketing Officer
Matthew Orlando General Counsel
Meredith Stevens Chief Operations Officer
Michael Wondrasch Chief Technology & Data Officer
Sofya Tsinis Head of Investor Relations

Latest SEC Filings

Date Type Title
Sep 29, 2026 4 Filing
Sep 29, 2026 4 Filing
Sep 29, 2026 4 Filing
Aug 06, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 06, 2026 10-Q Quarterly Report
Aug 06, 2026 8-K Current Report
Aug 04, 2026 4 Filing
Jul 01, 2026 4 Filing
Jul 01, 2026 4 Filing
Jun 12, 2026 4 Filing
View All SEC Filings ➞
Kenvue Inc.
Kenvue Inc. logo
Country United States
IPO Date May 4, 2023
Industry Household & Personal Products
Sector Consumer Defensive
Employees 21,890
CEO Kirk L. Perry

Contact Details

1 Kenvue Way Summit, New Jersey 07901 United States

Stock Details

Ticker Symbol KVUE
Exchange NYSE
Fiscal Year February - January
Reporting Currency USD
CIK Code 0001944048
CUSIP Number 49177J102
ISIN Number US49177J1025
SIC Code 2844

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.